Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W B Gerrits

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
The Netherlands Journal of Medicine|January 1, 1975
Fibrinogen and its derivatives in intravascular coagulation. A reviewW B Gerrits
Nederlands Tijdschrift Voor Geneeskunde|April 7, 1990
[Splenectomy as therapy for esophageal varices in a myeloproliferative syndrome]J Bender, W B Gerrits
European Journal of Haematology|May 1, 1993
Severe immunodeficiency in patients treated with fludarabine monophosphateP W Wijermans, W B Gerrits, H L Haak
Clinical and Laboratory Haematology|January 1, 1991
The effect of anticoagulants on the size of platelets in blood smears in the course of timeH Schonewille, H L Haak, H Kerkhofs, et al.
Thrombosis Research|August 1, 1974
Fibrinopeptide A immunoreactivity in human plasmaW B Gerrits, O T Flier, J van der Meer
Thrombosis and Haemostasis|August 13, 1990
Glycoprotein Ib polymorphism in a patient with Glanzmann's thrombasthenia type I (case report)J C Giltay, W B Gerrits, J A van Mourik
The Netherlands Journal of Medicine|January 1, 1986
Chronic lymphocytic leukaemia and associated second malignancyD J Kwekkeboom, L L Thomas, W B Gerrits, et al.
The Netherlands Journal of Medicine|April 1, 1993
Mitoxantrone, teniposide, chlorambucil and prednisone (MVLP) for relapsed non-Hodgkin's lymphoma. The impact of advanced age and performance statusH L Haak, W B Gerrits, P W Wijermans, et al.
Circulation|August 15, 2001
Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendencyA Srámek, J H Reiber, W B Gerrits, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 30, 1998
[The recommended daily intake of folic acid is insufficient for optimum homocysteine level]H P Willems, M Den Heijer, W B Gerrits, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The Netherlands Journal of Medicine|January 1, 1975
Fibrinogen and its derivatives in intravascular coagulation. A reviewW B Gerrits
Nederlands Tijdschrift Voor Geneeskunde|April 7, 1990
[Splenectomy as therapy for esophageal varices in a myeloproliferative syndrome]J Bender, W B Gerrits
European Journal of Haematology|May 1, 1993
Severe immunodeficiency in patients treated with fludarabine monophosphateP W Wijermans, W B Gerrits, H L Haak
Clinical and Laboratory Haematology|January 1, 1991
The effect of anticoagulants on the size of platelets in blood smears in the course of timeH Schonewille, H L Haak, H Kerkhofs, et al.
Thrombosis Research|August 1, 1974
Fibrinopeptide A immunoreactivity in human plasmaW B Gerrits, O T Flier, J van der Meer
Thrombosis and Haemostasis|August 13, 1990
Glycoprotein Ib polymorphism in a patient with Glanzmann's thrombasthenia type I (case report)J C Giltay, W B Gerrits, J A van Mourik
The Netherlands Journal of Medicine|January 1, 1986
Chronic lymphocytic leukaemia and associated second malignancyD J Kwekkeboom, L L Thomas, W B Gerrits, et al.
The Netherlands Journal of Medicine|April 1, 1993
Mitoxantrone, teniposide, chlorambucil and prednisone (MVLP) for relapsed non-Hodgkin's lymphoma. The impact of advanced age and performance statusH L Haak, W B Gerrits, P W Wijermans, et al.
Circulation|August 15, 2001
Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendencyA Srámek, J H Reiber, W B Gerrits, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 30, 1998
[The recommended daily intake of folic acid is insufficient for optimum homocysteine level]H P Willems, M Den Heijer, W B Gerrits, et al.
Pageof 3